Vimarsana
Biggest News Aggregation in the World

Page 14 - Jonathan Silverberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Silverberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Silverberg Today - Breaking & Trending Today

Beyond Dry Skin: How Eczema Impacts Emotional Well-Being - Vimarsana News

Beyond Dry Skin: How Eczema Impacts Emotional Well-Being

Created for Created for From Good Housekeeping for Created by Good Housekeeping for Beyond Dry Skin: How Eczema Impacts Emotional Well-Being Adults living with this common skin condition, and its associated symptoms including itch, are more likely to have a negative emotional impact, including feelings of anxiety and depression.¹ Ponomariova_MariaGetty Images For Karina Santana, now 27, eczema (also known as atopic dermatitis or atopic eczema) has been a part of her life since she was 8 or 9 years old when she first noticed the patches of dry skin on ...

Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial - Late-Breaker at Revolutionizing Atopic Dermatitis Conference - Vimarsana News

Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial - Late-Breaker at Revolutionizing Atopic Dermatitis Conference

Share this article Share this article SAN DIEGO, Dec. 11, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that data from the Phase 2b ADVISE trial evaluating the safety and efficacy of etrasimod, a highly selective, once-daily, oral sphingosine 1-phosphate (S1P) receptor modulator, in participants with moderate-to-severe atopic dermatitis (AD), will be presented at the Revolutionizing Atopic Dermatitis (RAD) 2020 Virtual Conference. "I am pleased to present the topline results from the ADVISE Phase 2 trial which support the rationale for etrasimod as a potentia...